Omzey - About the company
Omzey is a seed company based in Rome (Italy), founded in 2017 by Giovanni Stracquadaneo, Simone Gardini and Alessandro Rossi. It operates as a Provider of diagnostics solutions to manage, and optimize genetics laboratory workflows. Omzey has raised $1.63M in funding from Lumen Ventures. The company has 547 active competitors, including 108 funded and 43 that have exited. Its top competitors include companies like Benchling, Helix and Cellworks.
Company Details
Provider of diagnostics solutions to manage, and optimize genetics laboratory workflows. The company's product, JuliaOmix, cloud solution to support the complexity of genetics laboratory process that spans the genomic analysis cycle, from request to report, and clinical decision support.
- Website
- omzey.com
- Social
- Email ID
- *****@genomeup.com
Key Metrics
Founded Year
2017
Location
Rome, Italy
Stage
Seed
Total Funding
$1.63M in 4 rounds
Latest Funding Round
Investors
Ranked
77th among 547 active competitors
Employee Count
35 as on Jan 31, 2026
Sign up to download Omzey's company profile
Omzey's funding and investors
Omzey has raised a total funding of $1.63M over 4 rounds. Its first funding round was on Jun 01, 2018. Its latest funding round was a Grant (prize money) round on Dec 01, 2022 for $*****. 1 investor participated in its latest round. Omzey has 10 institutional investors.
Here is the list of recent funding rounds of Omzey:
Filter this list
Filter this listDate of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Dec 01, 2022 | 4680139 | Grant (prize money) | 7715393 | 5623158 | 6947805 | 1429318 |
Feb 08, 2022 | 1000449 | Seed | 4092485 | 5781660 | 4627491 | |
Jul 20, 2018 | 1474271 | Seed | 3815060 | 4947151 | 9405701 |
Access funding benchmarks and valuations. Sign up today!View details of Omzey's funding rounds and investors
Omzey's founders and board of directors
Founder? Claim ProfileThe founders of Omzey are Giovanni Stracquadaneo, Simone Gardini and Alessandro Rossi. Simone Gardini is the CEO of Omzey.
Here are the details of Omzey's key team members:
- Giovanni Stracquadaneo: Co-Founder of Omzey.
- Simone Gardini: Co-Founder & CEO of Omzey. Contact Info: 1 email address
- Alessandro Rossi: Co-Founder of Omzey.
View details of Omzey's Founder profiles and Board Members
Omzey's employee count trend
Omzey has 35 employees as of Jan 26. Here is Omzey's employee count trend over the years:
Uncover Omzey's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Omzey's Competitors and alternates
Top competitors of Omzey include Benchling, Helix and Cellworks. Here is the list of Top 10 competitors of Omzey, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Benchling 2012, San Francisco (United States), Series F | Provider of a cloud-based bioinformatics platform for biotech research | $412M | 73/100 | |
2nd |  Helix 2015, San Francisco (United States), Series E | Provider of a genomic database for clinical research | $435M | 71/100 | |
3rd | Cellworks 2005, San Jose (United States), Series B | Developer of a biosimulation platform | $16.5M | 65/100 | |
4th |  NTxBio 2016, Santa Fe (United States), Series B | Provider of bio informatics platform to develops biologics and therapeutics | $85.1M | 61/100 | |
5th |  Recludix Pharma 2020, San Diego (United States), Series A | Provider of the online platform for drug discovery and development | $60M | 60/100 | |
6th | Immuneering Corporation 2019, Cambridge (United States), Public | Provider of an AI-enabled bioinformatics platform for clinical solutions | $79M | 60/100 | |
7th | Cloud-based platform for storing and managing genomic data | $20M | 59/100 | ||
8th |  Latch 2021, San Francisco (United States), Series A | Provider of a web-based platform for genomic bioinformatics | $33M | 58/100 | |
9th | Genedata 1997, Basel (Switzerland), Acquired | Software solutions for drug discovery, industrial biotechnology, and life science research | - | 58/100 | |
10th |  Inpharmatica 1998, London (United Kingdom), Acquired | Developer of predictive informatics based platform for drug discovery | $75M | 58/100 | |
77th | Provider of diagnostics solutions to manage, and optimize genetics laboratory workflows | $1.63M | 38/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Omzey's competitors? Click here to see the top ones
Omzey's Investments and acquisitions
Omzey has made no investments or acquisitions yet.
Reports related to Omzey
Here is the latest report on Omzey's sector:
News related to Omzey
•
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Omzey
Explore our recently published companies
- Flok - Bend based, 2013 founded, Acquired company
- Platos Planet - Dubai based, 2015 founded, Unfunded company
- Shree Green Consultants - Surat based, 2017 founded, Unfunded company
- Otto - Hammersmith based, 2014 founded, Series A company
- Narayan Das Saraff - India based, 1958 founded, Unfunded company
- etcllp.in - Vadodara based, Unfunded company
